COVID-19
  • Article
  • Jan 13 2022

The University of Kentucky is participating in a nationwide study that seeks to understand why some people have prolonged symptoms (long COVID) or develop new or returning symptoms after an acute bout of SARS-CoV-2 infection.

  • Article
  • Dec 23 2021

The “Healthy Together Through Vaccinations” grant from the Kentucky Association of Health Plans (KAHP) aims to increase vaccine acceptance in the state.

  • Podcast
  • Dec 13 2021

Dr. Dutch returns to the ‘Behind the Blue’ podcast to discuss a wide range of pandemic topics including the Omicron variant, what it means for testing and vaccines, and best practices for the University community.

  • Podcast
  • Nov 29 2021

For this “UK at the Half,” Lisa Cassis, vice president for research at the University of Kentucky, shares how leaders across campus came together to find a path forward for research during the COVID-19 pandemic.

  • Article
  • Oct 12 2021

UK researchers studied pandemic-related impacts to food systems including changes in consumer purchasing behaviors, pandemic responses of different food system sectors, innovations and agency support.

  • Article
  • Oct 11 2021

The University of Kentucky is a site for KidCOVE, a national trial by Moderna to test the safety and effectiveness of its COVID-19 vaccine in children. The vaccine may protect young children 6 months to those under 12 years of age if they come into contact with the SARS-CoV-2 virus. 

  • Article
  • Sep 3 2021

Researchers found that most Americans were willing to take a COVID-19 test and valued having options when it came to how, when and where they were tested.

  • Article
  • Aug 31 2021

In January 2021, the Center for Muscle Biology (CMB) officially transferred from the UK College of Medicine to become a part of the UK College of Health Sciences.

  • Article
  • Aug 20 2021

Immunocompromised individuals who have previously received two doses of either the Pfizer or the Moderna COVID-19 vaccines are eligible to request a third dose.

  • Article
  • Aug 11 2021

The University of Kentucky has been selected as a site for a trial to assess dose levels of a Johnson & Johnson booster shot.